Evodiamine Mitigates Cellular Growth and Promotes Apoptosis by Targeting the c-Met Pathway in Prostate Cancer Cells

Evodiamine (EVO) is an indoloquinazoline alkaloid that exerts its various anti-oncogenic actions by blocking phosphatidylinositol-3-kinase/protein kinase B (PI3K/Akt), mitogen-activated protein kinase (MAPK), c-Met, and nuclear factor kappa B (NF-κB) signaling pathways, thus leading to apoptosis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Sun Tae, Um, Jae-Young, Chinnathambi, Arunachalam, Alharbi, Sulaiman Ali, Narula, Acharan S., Namjoshi, Ojas A., Blough, Bruce E., Ahn, Kwang Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144730/
https://www.ncbi.nlm.nih.gov/pubmed/32183146
http://dx.doi.org/10.3390/molecules25061320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144730/
https://www.ncbi.nlm.nih.gov/pubmed/32183146
http://dx.doi.org/10.3390/molecules25061320

Ejemplares similares